<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Trichomoniasis: Clinical manifestations and diagnosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Trichomoniasis: Clinical manifestations and diagnosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Trichomoniasis: Clinical manifestations and diagnosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jack D Sobel, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Caroline Mitchell, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert L Barbieri, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jeanne Marrazzo, MD, MPH, FACP, FIDSA
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kristen Eckler, MD, FACOG
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jul 17, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Trichomoniasis is a genitourinary infection with the protozoan
         <em>
          Trichomonas vaginalis
         </em>
         . It is the most common nonviral sexually transmitted infection (STI) worldwide. Females are affected more often than males. Trichomoniasis is one of the three common infectious causes of vaginal complaints among reproductive-aged females, along with bacterial vaginosis (BV) and candida vulvovaginitis, and a cause of non-gonococcal urethritis in males; however, the infection is often asymptomatic.
        </p>
        <p>
         Related topics on the approach to the evaluation of vulvovaginitis and urethritis are presented separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5477.html" rel="external">
          "Vaginitis in adults: Initial evaluation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/86698.html" rel="external">
          "Urethritis in adult males"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         In this topic, we use the terms "women" or "men" as they are used in the studies presented. However, we encourage the reader to consider the specific counseling and treatment needs of transgender and gender-diverse individuals.
        </p>
        <p class="headingAnchor" id="H148556694">
         <span class="h1">
          BACKGROUND
         </span>
        </p>
        <p class="headingAnchor" id="H770851">
         <span class="h2">
          Microbiology and transmission
         </span>
         <span class="headingEndMark">
          —
         </span>
         The organism responsible for trichomoniasis is the flagellated protozoan
         <em>
          T. vaginalis
         </em>
         , which principally infects the squamous epithelium in the urogenital tract: vagina, urethra, and paraurethral glands [
         <a href="#rid1">
          1
         </a>
         ]. Other less common sites include the cervix, bladder, Bartholin glands, and prostate. Positive tests from oral and rectal sites have also been reported [
         <a href="#rid2">
          2-4
         </a>
         ]. Humans are the only natural host, and it is the most common nonviral sexually transmitted infection (STI) worldwide [
         <a href="#rid1">
          1,5,6
         </a>
         ]. The parasite is a pear- or round-shaped organism with four anterior flagella and an undulating membrane that causes the characteristic motility seen on a diagnostic wet-mount slide of vaginal sections [
         <a href="#rid7">
          7
         </a>
         ]. (See
         <a class="local">
          'Preferred tests'
         </a>
         below.)
        </p>
        <p>
         Trichomoniasis is virtually always sexually transmitted [
         <a href="#rid8">
          8
         </a>
         ]. Although survival on fomites has been reported [
         <a href="#rid9">
          9
         </a>
         ], transmission by fomites has not been directly proven [
         <a href="#rid10">
          10
         </a>
         ]. Females can acquire the disease from both females and males, while males typically acquire the infection from females and do not usually transmit the infection to other males [
         <a href="#rid11">
          11-13
         </a>
         ]. The incubation period is unknown; however, in vitro studies suggest an incubation period of 4 to 28 days in approximately 50 percent of patients [
         <a href="#rid14">
          14
         </a>
         ]. Coexistence of
         <em>
          T. vaginalis
         </em>
         and bacterial vaginosis (BV) is common; coinfection rates ranging from 20 to 60 to 80 percent have been reported [
         <a href="#rid15">
          15,16
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5451.html" rel="external">
          "Bacterial vaginosis: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/113103.html" rel="external">
          "Bacterial vaginosis: Initial treatment"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h2">
          Prevalence
         </span>
         <span class="headingEndMark">
          —
         </span>
         Globally, the World Health Organization (WHO) estimates that more than 156 million new trichomoniasis infections occurred in 2020 [
         <a href="#rid17">
          17
         </a>
         ]. However, prevalence estimates vary according to the population studied (based on age and behavioral risk factors), community-wide disease prevalence, and method used for diagnosis. Trichomoniasis has been reported in transgender individuals both with and without gender-affirming surgery [
         <a href="#rid18">
          18
         </a>
         ]. Use of nucleic acid amplification tests (NAATs) results in higher prevalence rates compared with wet mount microscopy and vaginal pH testing [
         <a href="#rid19">
          19-22
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5477.html" rel="external">
          "Vaginitis in adults: Initial evaluation", section on 'Nucleic acid amplification tests (NAATs)'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         Available prevalence studies use self-reported gender when categorizing populations:
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prevalence in women
         </strong>
         – Reported prevalence rates in females vary widely. A meta-analysis of 18 studies including over 37,000 self-reported women from African countries noted prevalence rates ranging from 2 to nearly 30 percent; influencing factors included age group of study and risk status of the population [
         <a href="#rid23">
          23
         </a>
         ]. Studies that used NAATs to dete
         <em>
          ct T. vaginalis
         </em>
         in US women reported overall prevalence ranges from 8.7 to 27 percent [
         <a href="#rid24">
          24,25
         </a>
         ]. Prevalence varied by clinical setting (5 to 7 percent in family planning, internal medicine/family practice, and obstetrics and gynecology offices to 16 to 27 percent in prisons and STI clinics).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The age distribution of trichomoniasis infections in women appears to differ from other STIs. In a polymerase chain reaction (PCR) study of cervicovaginal samples obtained during gynecologic examinations, the peak rate of detection for
         <em>
          T. vaginalis
         </em>
         occurred in women ages 47 to 53 years, compared with 14 to 20 years for
         <em>
          Chlamydia trachomatis
         </em>
         [
         <a href="#rid26">
          26
         </a>
         ]. In addition, while rates of chlamydia infection rapidly declined after peak detection,
         <em>
          T. vaginalis
         </em>
         infections had a bimodal distribution with infection peaks occurring in women ages 21 to 22 years and 48 to 51 years.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prevalence in men
         </strong>
         – Studies using NAATs to screen US men at risk for STIs have reported
         <em>
          T. vaginalis
         </em>
         prevalence rates of 4 to nearly 10 percent [
         <a href="#rid22">
          22,25,27
         </a>
         ]. As with females, prevalence in males has been reported to increase with increasing age [
         <a href="#rid26">
          26,28
         </a>
         ]. When male sexual partners of females with confirmed
         <em>
          T. vaginalis
         </em>
         infection are studied,
         <em>
          T. vaginalis
         </em>
         can be identified in up to 70 percent [
         <a href="#rid29">
          29
         </a>
         ], although carriage in males is often self-limited.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H485591945">
         <span class="h2">
          Prevention
         </span>
         <span class="headingEndMark">
          —
         </span>
         The risk of acquiring
         <em>
          T. vaginalis
         </em>
         infection can be reduced by correct and consistent use of condoms and use of spermicidal agents such as
         <a class="drug drug_general" data-topicid="10170" href="/z/d/drug information/10170.html" rel="external">
          nonoxynol-9
         </a>
         [
         <a href="#rid13">
          13,30
         </a>
         ]. Discussion of contraceptive methods that reduce STI transmission are available separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5463.html" rel="external">
          "External (formerly male) condoms"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5471.html" rel="external">
          "Internal (formerly female) condoms"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3265.html" rel="external">
          "Pericoital (on demand) contraception: Diaphragm, cervical cap, spermicides, and sponge"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         The approach to treating sexual partners of individuals with confirmed trichomonas infection is presented in related content. (See
         <a class="medical medical_review" href="/z/d/html/139046.html" rel="external">
          "Trichomoniasis: Treatment", section on 'Sex partners'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3200958866">
         <span class="h1">
          SCREENING
         </span>
         <span class="headingEndMark">
          —
         </span>
         Routine screening for
         <em>
          T. vaginalis
         </em>
         infection is not advised for asymptomatic persons without HIV infection who do not have risk factors. However, as approximately 70 percent of individuals with
         <em>
          T. vaginalis
         </em>
         infection may be asymptomatic [
         <a href="#rid31">
          31
         </a>
         ] and infection can increase the risk of pelvic inflammatory disease as well as acquisition of HIV and other sexually transmitted infections (STIs), screening of various at-risk populations can been considered. The US Centers for Disease Control and Prevention (CDC) recommend screening for
         <em>
          T. vaginalis
         </em>
         in all HIV-infected females at their initial visit and annually [
         <a href="#rid13">
          13
         </a>
         ]. In addition, screening is reasonable for any person at increased risk of
         <em>
          Trichomonas
         </em>
         infection, including those in high-prevalence settings (eg, STI clinics, correction facilities), with new or multiple sex partners, with a history of transactional sex work, or with a history of STIs. Additional discussion related to screening for
         <em>
          T. vaginalis
         </em>
         is available separately. (See
         <a class="medical medical_review" href="/z/d/html/7596.html" rel="external">
          "Screening for sexually transmitted infections", section on 'Assessing risk'
         </a>
         .)
        </p>
        <p>
         By contrast, testing for
         <em>
          T. vaginalis
         </em>
         is indicated for any sexually active individual with symptoms suggestive of trichomoniasis infection, particularly those with abnormal vaginal or urethral pain or discharge.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="local">
          'Clinical features and consequences'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="local">
          'Diagnostic evaluation'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          CLINICAL FEATURES AND CONSEQUENCES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Trichomonas infection ranges from an acute, severe inflammatory disease to an asymptomatic carrier state.
        </p>
        <p class="headingAnchor" id="H91868841">
         <span class="h2">
          Female
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Acute infection
         </strong>
         – Symptoms of infection in females include a purulent, malodorous, thin vaginal discharge associated with burning, pruritus, dysuria, frequency, lower abdominal pain, and/or dyspareunia [
         <a href="#rid32">
          32
         </a>
         ]. However, typical symptoms may occur in only 11 to 17 percent of those with confirmed infection; thus, providers should have a low threshold to test for trichomonas when any vaginal discomfort is present [
         <a href="#rid33">
          33
         </a>
         ]. Symptoms may be worse during menstruation [
         <a href="#rid34">
          34
         </a>
         ]. Postcoital bleeding can occur.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Chronic infection
         </strong>
         – Signs and symptoms of chronic infection are milder and may include pruritus and dyspareunia, with scanty vaginal discharge. Rates of asymptomatic infection from 66 to 85 percent have been reported; results vary by test used and population studied [
         <a href="#rid13">
          13,31,35
         </a>
         ]. Asymptomatic carriage can persist for prolonged periods of time (at least three months), although many will ultimately develop symptoms [
         <a href="#rid7">
          7,13
         </a>
         ]. Thus, it is often not possible to ascertain when or from whom the infection was acquired [
         <a href="#rid36">
          36,37
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Physical examination findings
         </strong>
         – Physical examination often reveals erythema of the vulva and vaginal mucosa. The classically described green-yellow, frothy, malodorous vaginal discharge occurs in 10 to 30 percent of symptomatic women [
         <a href="#rid38">
          38
         </a>
         ]. Punctate hemorrhages may be visible on the vaginal mucosa and/or cervix (ie, strawberry cervix or colpitis macularis) in only a small percent of cases  (
         <a class="graphic graphic_picture graphicRef102398" href="/z/d/graphic/102398.html" rel="external">
          picture 1
         </a>
         ) [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical consequences
         </strong>
         – Consequences of trichomoniasis vary by population:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Nonpregnant patients with a vagina
         </strong>
         – Untreated
         <em>
          T. vaginalis
         </em>
         infection may result in:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Urethritis or cystitis [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Posthysterectomy cuff cellulitis or abscess [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Pelvic inflammatory disease [
         <a href="#rid41">
          41,42
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Infertility [
         <a href="#rid43">
          43
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Increased risk of HIV acquisition and/or transmission – Trichomoniasis has been associated with increased risk of HIV susceptibility (up to twofold increase for females) [
         <a href="#rid44">
          44-46
         </a>
         ] and transmission to uninfected partners [
         <a href="#rid47">
          47-49
         </a>
         ]. There is some evidence that treatment of trichomoniasis reduces HIV shedding [
         <a href="#rid47">
          47,48,50
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Acquisition of other sexually transmitted infections (STIs) – Trichomoniasis has been associated with increased acquisition of other STIs (including herpes simplex virus 2, chlamydia, gonorrhea, and human papilloma virus [HPV]) [
         <a href="#rid24">
          24,51,52
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Cervical neoplasia – While multiple studies have reported an association between trichomoniasis and cervical neoplasia, some antedated testing for HPV coinfection [
         <a href="#rid53">
          53-56
         </a>
         ]. Subsequent studies have reported an association between infection with
         <em>
          T. vaginalis
         </em>
         and high-risk HPV subtypes, which suggests an indirect link between
         <em>
          T. vaginalis
         </em>
         and cervical neoplasia [
         <a href="#rid57">
          57,58
         </a>
         ]. A study of 324 Tanzanian women reported that those
         <em>
          T. vaginalis
         </em>
         were 6.5 times more likely to have high-risk HPV [
         <a href="#rid52">
          52
         </a>
         ]. Similarly, a study of 536 Brazilian women reported a 2.2-fold increased odds for high-risk HPV in individuals with concurrent trichomonas, a threefold higher odds for low-grade squamous intraepithelial lesions, and 12-fold higher odds for atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion (ASC-H) [
         <a href="#rid59">
          59
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Pregnant individuals
         </strong>
         –
         <em>
          T. vaginalis
         </em>
         infection during pregnancy is associated with adverse obstetric outcomes including premature rupture of the membranes, preterm delivery, and delivery of a low birth weight infant [
         <a href="#rid35">
          35,60-64
         </a>
         ]. In a meta-analysis of 19 studies that evaluated the association between
         <em>
          T. vaginalis
         </em>
         and perinatal outcomes, trichomoniasis during pregnancy was associated with a 27 percent increased risk of preterm birth (odds ratio [OR] 1.27, 95% CI 1.08-1.50), 87 percent increased risk of prelabor rupture of membranes (OR 1.87, 95% CI 1.53-2.29), and more than double the risk of low birthweight (OR 2.12, 95% CI 1.15-3.91) [
         <a href="#rid65">
          65
         </a>
         ]. Whether treatment in pregnancy affects these risks, positively or negatively, is unclear [
         <a href="#rid13">
          13
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/139046.html" rel="external">
          "Trichomoniasis: Treatment", section on 'Pregnant'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H9535475">
         <span class="h2">
          Male
         </span>
         <span class="headingEndMark">
          —
         </span>
         Trichomoniasis can cause symptoms of urethritis in males. When present, symptoms consist of a clear or mucopurulent urethral discharge and/or dysuria and are the same as for urethritis from any cause [
         <a href="#rid66">
          66,67
         </a>
         ]. There may also be mild pruritus or a burning sensation in the penis after sexual activity. However,
         <em>
          T. vaginalis
         </em>
         infection is asymptomatic in over three-quarters of cases and often transient (spontaneous resolution within 10 days) [
         <a href="#rid29">
          29,68
         </a>
         ], although untreated infection can persist for months [
         <a href="#rid69">
          69
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/86698.html" rel="external">
          "Urethritis in adult males", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p>
         <em>
          T. vaginalis
         </em>
         has also been associated with prostatitis [
         <a href="#rid70">
          70,71
         </a>
         ], epididymitis, slowed sperm motility and infertility [
         <a href="#rid72">
          72,73
         </a>
         ], and, possibly, prostate cancer [
         <a href="#rid74">
          74,75
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6938.html" rel="external">
          "Risk factors for prostate cancer", section on 'Trichomonas vaginalis infection'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H594983079">
         <span class="h2">
          Newborns
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infants born to an infected person may contract infection during delivery. Signs and symptoms in neonates may include fever, respiratory problems, urinary tract infection, nasal discharge, and, in females, vaginal discharge [
         <a href="#rid76">
          76-79
         </a>
         ]. Treatment of asymptomatic infants is not necessary as spontaneous resolution will occur when estrogen levels wane to normal prepubescent levels [
         <a href="#rid68">
          68
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of
         <em>
          T. vaginalis
         </em>
         is based on testing (positive nucleic acid amplification test [NAAT], motile trichomonads on wet mount of vaginal secretions, positive culture, or positive rapid antigen or nucleic acid probe test) that confirms
         <em>
          T. vaginalis
         </em>
         infection
         <em>
         </em>
         [
         <a href="#rid80">
          80
         </a>
         ]. (See
         <a class="local">
          'Preferred tests'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H3968142499">
         <span class="h1">
          DIAGNOSTIC EVALUATION
         </span>
        </p>
        <p class="headingAnchor" id="H1116946821">
         <span class="h2">
          Preferred tests
         </span>
         <span class="headingEndMark">
          —
         </span>
         Preferred diagnostic tests include nucleic acid amplification tests (NAATs, for vaginal or urethral discharge) or testing of vaginal pH and microscopy. Approach is based on test availability and provider training  (
         <a class="graphic graphic_algorithm graphicRef138432" href="/z/d/graphic/138432.html" rel="external">
          algorithm 1
         </a>
         ).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Explanation and comparison of test types
         </strong>
         – Comparison of testing methods is reviewed in detail in related content. (See
         <a class="medical medical_review" href="/z/d/html/5477.html" rel="external">
          "Vaginitis in adults: Initial evaluation", section on 'Test vaginal discharge'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment of positive test
         </strong>
         – Treatment of individuals with a positive test result is presented separately. (See
         <a class="medical medical_review" href="/z/d/html/139046.html" rel="external">
          "Trichomoniasis: Treatment"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1647709552">
         <span class="h3">
          Nucleic acid amplification tests (all patients)
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nucleic acid amplification tests (NAATs) are preferred for diagnosing
         <em>
          T. vaginalis
         </em>
         infection in all patients (female and male) because of the high sensitivity and specificity (both approaching 100 percent) compared with microscopy (vaginal discharge) or culture (vaginal or penile secretions)  (
         <a class="graphic graphic_table graphicRef141997" href="/z/d/graphic/141997.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid13">
          13,19-21,81-83
         </a>
         ]. Limitations of NAATs, compared with microscopy for female patients, include longer turnaround time and higher cost [
         <a href="#rid19">
          19-21
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5477.html" rel="external">
          "Vaginitis in adults: Initial evaluation", section on 'Nucleic acid amplification tests (NAATs)'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Male patients
         </strong>
         – NAAT testing is typically performed on a urethral swab, although positive NAATs of rectal swabs have also been reported [
         <a href="#rid2">
          2
         </a>
         ]. Not all commercial NAAT assays are approved for use in male patients; clinicians should speak with their lab to understand test availability. (See
         <a class="medical medical_review" href="/z/d/html/86698.html" rel="external">
          "Urethritis in adult males"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Female patients
         </strong>
         – NAAT may be the primary test or used as a secondary test for female patients with concerning symptoms and/or vaginal discharge but negative microscopy results. (See
         <a class="medical medical_review" href="/z/d/html/5477.html" rel="external">
          "Vaginitis in adults: Initial evaluation", section on 'pH and microscopy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1052888695">
         <span class="h3">
          pH and microscopy of vaginal discharge
         </span>
         <span class="headingEndMark">
          —
         </span>
         If NAAT is not available, vaginal discharge can be evaluated with pH testing and microscopy. pH and microscopy are convenient, provide results during the office visit, and cost less than laboratory tests but require a trained provider and are less accurate  (
         <a class="graphic graphic_table graphicRef141997" href="/z/d/graphic/141997.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid13">
          13,20,21
         </a>
         ]. Compared with NAATs, microscopy has a reported sensitivity of 26 to 68 percent [
         <a href="#rid84">
          84,85
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5477.html" rel="external">
          "Vaginitis in adults: Initial evaluation", section on 'pH and microscopy'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         Specific to trichomoniasis, typical findings include:
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Microscopy
         </strong>
         – The presence of motile trichomonads on wet mount is diagnostic of infection, but they are identified in only 60 to 70 percent of culture-confirmed cases  (
         <a class="graphic graphic_picture graphicRef71667" href="/z/d/graphic/71667.html" rel="external">
          picture 2
         </a>
         and
         <a class="graphic graphic_figure graphicRef131170" href="/z/d/graphic/131170.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid86">
          86
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The motion is jerky and spinning  (
         <a class="graphic graphic_movie graphicRef89261" href="/z/d/graphic/89261.html" rel="external">
          movie 1
         </a>
         and
         <a class="graphic graphic_movie graphicRef90675" href="/z/d/graphic/90675.html" rel="external">
          movie 2
         </a>
         ). Organisms remain motile for only 10 to 20 minutes after collection of the sample. The slide should be evaluated soon after obtaining the specimen as sensitivity decreases over time, with up to 20 percent decrease reported one hour after collection [
         <a href="#rid13">
          13,87,88
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Fixation and staining is not useful becau
         <em>
          se T. vaginalis
         </em>
         may not have the typical pear-shaped flagellated form; instead, it may resemble polymorphonuclear leukocytes or lose morphologic characteristics during fixation and staining, making the etiologic identification difficult [
         <a href="#rid89">
          89
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          pH and other
         </strong>
         – Findings with
         <em>
          T. vaginalis
         </em>
         infection include an elevated vaginal pH (&gt;4.5), although the pH can occasionally be normal in the presence of infection, and an increase in polymorphonuclear leukocytes on wet mount microscopy. However, these additional findings are not diagnostic as they can be found in other vaginal infections  (
         <a class="graphic graphic_table graphicRef68759" href="/z/d/graphic/68759.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p>
        </p>
        <p>
         pH and microscopy (either wet mount or gram stain) are not applicable for urethral or anal specimens.
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          Saline
         </a>
         microscopy of a urethral swab specimen from male patients has low sensitivity and is not recommended. (See
         <a class="medical medical_review" href="/z/d/html/86698.html" rel="external">
          "Urethritis in adult males"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1899232978">
         <span class="h2">
          Less accurate
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Culture
         </strong>
         – Culture is performed if neither NAATs nor microscopy are available. Culture of vaginal secretions on Diamond's medium was the historic gold standard method for diagnosing
         <em>
          T. vaginalis
         </em>
         infection before the development of molecular detection methods (NAATs); however, this is not as sensitive as NAATs [
         <a href="#rid90">
          90
         </a>
         ]. Compared with NAATs, the sensitivity of culture for trichomonas has been reported between 45 and 93 percent with specificity up to 100 percent [
         <a href="#rid13">
          13,20,81,91-94
         </a>
         ]. Although this test is not widely available and takes up to seven days to obtain a result, culture may be useful in patients with elevated vaginal pH and increased numbers of polymorphonuclear leukocytes but an absence of motile trichomonads and clue cells on wet mount, when microscopy is unavailable or yields ambiguous results, or when NAATs are not available. It is also useful when drug susceptibility testing is needed in cases of persistent infection. The "InPouch"
         <em>
          T. vaginalis
         </em>
         culture system has high sensitivity (over 80 percent) and is commercially available [
         <a href="#rid95">
          95,96
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cervical cytology
         </strong>
         – Trichomonads are sometimes reported as an incidental finding on tests performed for cervical cancer screening.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Liquid-based cervical cytology
         </strong>
         – Liquid-based cervical cytology is not a sensitive test for trichomoniasis but specificity is high. Therefore, treating individuals with trichomonads noted on liquid-based cervical cytology is reasonable. In a study that performed both liquid-based cervical cytology and culture for
         <em>
          T. vaginalis
         </em>
         on 203 consecutive self-reported women, 28 had a liquid-based smear positive for trichomonads, and 44 had positive cultures [
         <a href="#rid97">
          97
         </a>
         ]. Although sensitivity of liquid-based smears for
         <em>
          Trichomonas
         </em>
         infection was low (61 percent), specificity was high (99 percent). A second study using polymerase chain reaction (PCR) testing of stored samples confirmed
         <em>
          T. vaginalis
         </em>
         in 50 out of 51 samples called positive by cytology and identified the organism in 2 out of 195 samples that had been read as negative. For this population, cytology had a sensitivity of 96.2 percent and specificity of 99.5 percent [
         <a href="#rid98">
          98
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Conventional Pap smear
         </strong>
         – Conventional Pap smear should not be used to diagnose trichomoniasis. Although the sensitivity is similar (51 to 63 percent) to liquid-based tests, false-positive results are common (7 percent) [
         <a href="#rid99">
          99
         </a>
         ]. This makes the positive predictive value poor in a low prevalence population. Asymptomatic individuals with trichomonads identified on a conventional Pap smear should be evaluated by NAAT, wet mount microscopy, or culture (selection is based on availability).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1537462695">
         <span class="h2">
          Additional STI testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Individuals undergoing testing for trichomoniasis are generally offered testing for other sexually transmitted infections (STIs), including gonorrhea, chlamydia, syphilis, and HIV [
         <a href="#rid13">
          13
         </a>
         ]. Testing for STIs is presented separately. (See
         <a class="medical medical_review" href="/z/d/html/7596.html" rel="external">
          "Screening for sexually transmitted infections", section on 'Screening recommendations'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2221246166">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
        </p>
        <p class="headingAnchor" id="H2329318027">
         <span class="h2">
          Female patients
         </span>
         <span class="headingEndMark">
          —
         </span>
         Vaginal discharge is a nonspecific symptom that can be caused by vaginal infections, cervical infections, and, less commonly, atrophy related to hypoestrogenism, and irritation.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Vaginal infections
         </strong>
         – The most common infections responsible for vaginal discharge, odor, pruritus, and/or discomfort are bacterial vaginosis (BV),
         <em>
          Candida
         </em>
         vulvovaginitis, and trichomoniasis; these infections account for over 90 percent of cases [
         <a href="#rid100">
          100
         </a>
         ]. The clinical features that distinguish among these infections are presented in the table  (
         <a class="graphic graphic_table graphicRef68759" href="/z/d/graphic/68759.html" rel="external">
          table 2
         </a>
         ). Detailed discussions of the clinical manifestations and management of BV and vulvovaginal candidiasis are presented separately:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5451.html" rel="external">
          "Bacterial vaginosis: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/113103.html" rel="external">
          "Bacterial vaginosis: Initial treatment"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5452.html" rel="external">
          "Candida vulvovaginitis: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/115170.html" rel="external">
          "Candida vulvovaginitis in adults: Treatment of acute infection"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cervical infections
         </strong>
         – The sexually transmitted cervical infections gonorrhea and chlamydia also cause symptomatic vaginal discharge, but less commonly than vaginal infections [
         <a href="#rid101">
          101,102
         </a>
         ]. In two studies of self-reported women presenting with symptomatic vaginal discharge in resource-limited countries, cervical infection with either gonorrhea or chlamydia was present in 5 to 24 percent of patients compared with vaginal infection (ie, BV, vulvovaginal candidiasis, or trichomoniasis), which was present in over 50 percent of patients [
         <a href="#rid101">
          101,102
         </a>
         ]. Organism-specific testing is required to identify the infectious cause(s) of vaginal discharge. Clinical presentations and management of cervical sexually transmitted infections (STIs) are discussed elsewhere:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/15893.html" rel="external">
          "Clinical manifestations and diagnosis of
          <i>
           Neisseria gonorrhoeae
          </i>
          infection in adults and adolescents"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/15892.html" rel="external">
          "Treatment of uncomplicated gonorrhea (
          <i>
           Neisseria gonorrhoeae
          </i>
          infection) in adults and adolescents"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/83019.html" rel="external">
          "Clinical manifestations and diagnosis of
          <i>
           Chlamydia trachomatis
          </i>
          infections"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7579.html" rel="external">
          "Treatment of
          <i>
           Chlamydia trachomatis
          </i>
          infection"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other
         </strong>
         – Less common causes of vaginal discharge that could be mistaken for trichomoniasis include vaginal atrophy/atrophic vaginitis in hypoestrogenic females, retained foreign body, irritants and allergens (ie, dermatitis), desquamative inflammatory vaginitis, and several rare entities, including some systemic medical disorders. Targeted testing is performed to exclude infection, including
         <em>
          T. vaginalis
         </em>
         . Once infectious etiologies have been excluded, then the evaluation continues to exclude noninfectious causes. (See
         <a class="medical medical_review" href="/z/d/html/5477.html" rel="external">
          "Vaginitis in adults: Initial evaluation", section on 'No diagnosis after initial evaluation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1132603884">
         <span class="h2">
          Male patients
         </span>
         <span class="headingEndMark">
          —
         </span>
         Urethritis in males is typically caused by a sexually transmitted pathogen. As with vaginal discharge, urethritis is a nonspecific symptom and testing is performed to identify or exclude infectious organisms, most commonly
         <em>
          Neisseria gonorrhoeae,
         </em>
         <em>
          Chlamydia trachomatis,
         </em>
         and
         <em>
          Mycoplasma genitalium.
         </em>
         The evaluation and management of patients with urethritis is presented elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/86698.html" rel="external">
          "Urethritis in adult males"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2398318720">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/111582.html" rel="external">
          "Society guideline links: Sexually transmitted infections"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H20072173">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/16999.html" rel="external">
          "Patient education: Trichomoniasis (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1239595150">
         <span class="h1">
          RESOURCES FOR PATIENTS AND CLINICIANS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The following resources are available to patients and clinicians at no cost.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         World Health Organization –
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.who.int%2Fpublications%2Fi%2Fitem%2F9789240024168&amp;token=mr3MkQMxxRm373pPGLTYB%2B8L7rJeOJtqYOfpSLq18h7bLDDnWC3XicBcpsIGU3t1LZa9hAfcC%2BHlHSr8RBLKzQ%3D%3D&amp;TOPIC_ID=5453" target="_blank">
          Guidelines for the management of symptomatic sexually transmitted infections
         </a>
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         National Health Service (UK) –
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.nhs.uk%2Fconditions%2Ftrichomoniasis%2F&amp;token=lblfowwGB6QwC91WNuiIf8xpMoOf93JvR%2B5FfnZb735o2QcnvUhNF9CurY%2FgCefa52Q0euYEQoD%2Fimi0oqCrZA%3D%3D&amp;TOPIC_ID=5453" target="_blank">
          Trichomoniasis
         </a>
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         US Centers for Disease Control and Prevention –
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fstd%2Ftreatment-guidelines%2Fdefault.htm&amp;token=GG%2FgjfxydbWPRfxXxvkuO3Z7rCvPfYCbHpI0XhRbEzgb1PiLFQLuos1hzlgAVwGZBa1nyF6yQEYtZyuOXda5Pg%3D%3D&amp;TOPIC_ID=5453" target="_blank">
          STI Treatment Guidelines
         </a>
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Microbiology
         </strong>
         – Trichomoniasis is caused by the protozoa
         <em>
          Trichomonas vaginalis
         </em>
         . The organism principally infects the squamous epithelium in the urogenital tract: vagina, urethra, and paraurethral glands. Less common sites include the cervix, bladder, Bartholin glands, and prostate. Humans are the only natural host and it is virtually always sexually transmitted. Coinfection with other sexually transmitted infections (STIs) and bacterial vaginosis (BV) is common. (See
         <a class="local">
          'Microbiology and transmission'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prevention
         </strong>
         – The risk of acquiring
         <em>
          T. vaginalis
         </em>
         infection can be reduced by correct and consistent use of condoms and use of spermicidal agents such as
         <a class="drug drug_general" data-topicid="10170" href="/z/d/drug information/10170.html" rel="external">
          nonoxynol-9
         </a>
         . (See
         <a class="local">
          'Prevention'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Screening
         </strong>
         – Routine screening for
         <em>
          T. vaginalis
         </em>
         infection is not advised for asymptomatic persons without HIV infection who do not have risk factors. However, as infection with
         <em>
          T. vaginalis
         </em>
         is often asymptomatic and has clinical consequences, screening can be considered for high-risk populations but is not standardized. (See
         <a class="local">
          'Screening'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         By contrast, testing for
         <em>
          T. vaginalis
         </em>
         is indicated for any sexually active individual with symptoms suggestive of trichomonas infection, particularly those with abnormal vaginal or urethral pain or discharge. However, typical symptoms may occur in only 11 to 17 percent of those with confirmed infection; thus, providers should have a low threshold to test for trichomonas when any vaginal discomfort is present. (See
         <a class="local">
          'Clinical features and consequences'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features and sequelae
         </strong>
         – Trichomonas infection ranges from an acute, severe inflammatory disease to an asymptomatic carrier state. (See
         <a class="local">
          'Clinical features and consequences'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Females
         </strong>
         – Signs and symptoms include a purulent, malodorous, thin vaginal discharge with associated burning, pruritus, dysuria, frequency, and/or dyspareunia.
         <em>
          T. vaginalis
         </em>
         has been associated with a range of adverse reproductive health outcomes, including posthysterectomy cuff cellulitis or abscess, pelvic inflammatory disease, infertility, and preterm birth. It may also increase susceptibility to HIV-1 infection and other STIs. (See
         <a class="local">
          'Female'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Males
         </strong>
         – Symptoms, when present, are the same as for urethritis from any cause and consist of a clear or mucopurulent urethral discharge and/or dysuria. However,
         <em>
          T. vaginalis
         </em>
         infection is asymptomatic in over three-quarters of cases, is often transient (spontaneous resolution within 10 days), yet can also persist for months. As a result, it is often not possible to ascertain when or from whom the infection was acquired. (See
         <a class="local">
          'Male'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Newborns
         </strong>
         – Infants born to an infected person may contract infection during delivery. Signs and symptoms in neonates may include fever, respiratory problems, urinary tract infection, nasal discharge, and, in females, vaginal discharge [
         <a href="#rid76">
          76-79
         </a>
         ]. Treatment of asymptomatic infants is not necessary. (See
         <a class="local">
          'Newborns'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – Preferred tests for
         <em>
          T. vaginalis
         </em>
         infection include nucleic acid amplification tests (NAATs, performed on vaginal or penile discharge) or microscopic evaluation of vaginal discharge that confirms motile trichomonads  (
         <a class="graphic graphic_picture graphicRef71667" href="/z/d/graphic/71667.html" rel="external">
          picture 2
         </a>
         ). Culture and liquid-based cervical cytology can diagnose trichomonas but are not preferred tests because of lower sensitivity compared with NAATs. (See
         <a class="local">
          'Diagnostic evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis
         </strong>
         – Vaginal discharge is a nonspecific symptom that can be caused by vaginal infections, cervical infections, and, less commonly, atrophy related to hypoestrogenism, and irritation. Urethritis in males is typically caused by a sexually transmitted pathogen. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Kissinger PJ, Gaydos CA, Seña AC, et al. Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines. Clin Infect Dis 2022; 74:S152.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Munson E, Reynoso A, Pass M, et al. Comprehensive Molecular Screening in a Cohort of Young Men Who Have Sex With Men and Transgender Women: Effect of Additive Rectal Specimen Source Collection and Analyte Testing. Sex Transm Dis 2020; 47:748.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Francis SC, Kent CK, Klausner JD, et al. Prevalence of rectal Trichomonas vaginalis and Mycoplasma genitalium in male patients at the San Francisco STD clinic, 2005-2006. Sex Transm Dis 2008; 35:797.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carter-Wicker K, Utuama O, Omole F. Can trichomoniasis cause pharyngitis? A case report. SAGE Open Med Case Rep 2016; 4:2050313X16682132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal complaints. JAMA 2004; 291:1368.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maritz JM, Land KM, Carlton JM, Hirt RP. What is the importance of zoonotic trichomonads for human health? Trends Parasitol 2014; 30:333.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Petrin D, Delgaty K, Bhatt R, Garber G. Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev 1998; 11:300.
          </a>
         </li>
         <li class="breakAll">
          Trichomoniasis- CDC Fact Sheet. Centers for Disease Control and Prevention. January 31, 2017. www.cdc.gov/std/trichomonas/stdfact-trichomoniasis.htm (Accessed on March 05, 2018).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burch TA, Rees CW, Reardon LV. Epidemiological studies on human trichomoniasis. Am J Trop Med Hyg 1959; 8:312.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Crucitti T, Jespers V, Mulenga C, et al. Non-sexual transmission of Trichomonas vaginalis in adolescent girls attending school in Ndola, Zambia. PLoS One 2011; 6:e16310.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mayer KH, Bush T, Henry K, et al. Ongoing sexually transmitted disease acquisition and risk-taking behavior among US HIV-infected patients in primary care: implications for prevention interventions. Sex Transm Dis 2012; 39:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kelley CF, Rosenberg ES, OʼHara BM, et al. Prevalence of urethral Trichomonas vaginalis in black and white men who have sex with men. Sex Transm Dis 2012; 39:739.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021; 70:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hesseltine H. Experimental human vaginal trichomoniasis. J Infect Dis 1942; 71:127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sobel JD, Subramanian C, Foxman B, et al. Mixed vaginitis-more than coinfection and with therapeutic implications. Curr Infect Dis Rep 2013; 15:104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaydos CA, Beqaj S, Schwebke JR, et al. Clinical Validation of a Test for the Diagnosis of Vaginitis. Obstet Gynecol 2017; 130:181.
          </a>
         </li>
         <li class="breakAll">
          Fact Sheet - Sexually Transmitted Infections (STIs). World Health Organization. Available at: https://www.who.int/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis) (Accessed on September 30, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poteat T, White RH, Footer KHA, et al. Characterising HIV and STIs among transgender female sex workers: a longitudinal analysis. Sex Transm Infect 2021; 97:226.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwebke JR, Gaydos CA, Nyirjesy P, et al. Diagnostic Performance of a Molecular Test versus Clinician Assessment of Vaginitis. J Clin Microbiol 2018; 56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Danby CS, Althouse AD, Hillier SL, Wiesenfeld HC. Nucleic Acid Amplification Testing Compared With Cultures, Gram Stain, and Microscopy in the Diagnosis of Vaginitis. J Low Genit Tract Dis 2021; 25:76.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Broache M, Cammarata CL, Stonebraker E, et al. Performance of a Vaginal Panel Assay Compared With the Clinical Diagnosis of Vaginitis. Obstet Gynecol 2021; 138:853.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Muzny CA, Blackburn RJ, Sinsky RJ, et al. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic. Clin Infect Dis 2014; 59:834.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Torrone EA, Morrison CS, Chen PL, et al. Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studies. PLoS Med 2018; 15:e1002511.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ginocchio CC, Chapin K, Smith JS, et al. Prevalence of Trichomonas vaginalis and coinfection with Chlamydia Trachomatis and neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay. J Clin Microbiol 2012; 50:2601.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwebke J, Merriweather A, Massingale S, et al. Screening for Trichomonas vaginalis in a Large High-Risk Population: Prevalence Among Men and Women Determined by Nucleic Acid Amplification Testing. Sex Transm Dis 2018; 45:e23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stemmer SM, Mordechai E, Adelson ME, et al. Trichomonas vaginalis is most frequently detected in women at the age of peri-/premenopause: an unusual pattern for a sexually transmitted pathogen. Am J Obstet Gynecol 2018; 218:328.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Territo HM, Wrotniak BH, Verni C, Burstein GR. Trichomonas Infection Rates in Males Presenting to the Emergency Department for Sexually Transmitted Infections. J Emerg Med 2022; 62:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaydos CA, Barnes MR, Quinn N, et al. Trichomonas vaginalis infection in men who submit self-collected penile swabs after internet recruitment. Sex Transm Infect 2013; 89:504.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seña AC, Miller WC, Hobbs MM, et al. Trichomonas vaginalis infection in male sexual partners: Implications for diagnosis, treatment, and prevention. Clin Infect Dis 2007; 44:13.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           d'Oro LC, Parazzini F, Naldi L, La Vecchia C. Barrier methods of contraception, spermicides, and sexually transmitted diseases: A review. Genitourin Med 1994; 70:410.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peterman TA, Tian LH, Metcalf CA, et al. High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening. Ann Intern Med 2006; 145:564.
          </a>
         </li>
         <li class="breakAll">
          Trichomoniasis - CDC Fact Sheet. National Center for HI/AIDS, Viral Hepatitis, STD, and TB Prevention. Division of STD Prevention. Centers for Disease Control and Prevention. 2017. Available at: www.cdc.gov/std/trichomonas/Trichomoniasis-FS-July-2017.pdf (Accessed on March 05, 2018).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Landers DV, Wiesenfeld HC, Heine RP, et al. Predictive value of the clinical diagnosis of lower genital tract infection in women. Am J Obstet Gynecol 2004; 190:1004.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heine P, McGregor JA. Trichomonas vaginalis: A reemerging pathogen. Clin Obstet Gynecol 1993; 36:137.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cotch MF, Pastorek JG 2nd, Nugent RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 1997; 24:353.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Der Pol B, Kraft CS, Williams JA. Use of an adaptation of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens. J Clin Microbiol 2006; 44:366.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Der Pol B, Williams JA, Orr DP, et al. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women. J Infect Dis 2005; 192:2039.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwebke JR, Burgess D. Trichomoniasis. Clin Microbiol Rev 2004; 17:794.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fouts AC, Kraus SJ. Trichomonas vaginalis: Reevaluation of its clinical presentation and laboratory diagnosis. J Infect Dis 1980; 141:137.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Soper DE, Bump RC, Hurt WG. Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. Am J Obstet Gynecol 1990; 163:1016.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moodley P, Wilkinson D, Connolly C, et al. Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin Infect Dis 2002; 34:519.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wiringa AE, Ness RB, Darville T, et al. Trichomonas vaginalis, endometritis and sequelae among women with clinically suspected pelvic inflammatory disease. Sex Transm Infect 2020; 96:436.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grodstein F, Goldman MB, Cramer DW. Relation of tubal infertility to history of sexually transmitted diseases. Am J Epidemiol 1993; 137:577.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study. AIDS 1993; 7:95.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sorvillo F, Kerndt P. Trichomonas vaginalis and amplification of HIV-1 transmission. Lancet 1998; 351:213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McClelland RS, Sangare L, Hassan WM, et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 2007; 195:698.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang CC, McClelland RS, Reilly M, et al. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis 2001; 183:1017.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kissinger P, Amedee A, Clark RA, et al. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis 2009; 36:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mostad SB, Overbaugh J, DeVange DM, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 1997; 350:922.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kissinger P, Adamski A. Trichomoniasis and HIV interactions: A review. Sex Transm Infect 2013; 89:426.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gottlieb SL, Douglas JM Jr, Foster M, et al. Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling. J Infect Dis 2004; 190:1059.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lazenby GB, Taylor PT, Badman BS, et al. An association between Trichomonas vaginalis and high-risk human papillomavirus in rural Tanzanian women undergoing cervical cancer screening. Clin Ther 2014; 36:38.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang ZF, Begg CB. Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies. Int J Epidemiol 1994; 23:682.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yap EH, Ho TH, Chan YC, et al. Serum antibodies to Trichomonas vaginalis in invasive cervical cancer patients. Genitourin Med 1995; 71:402.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yang S, Zhao W, Wang H, et al. Trichomonas vaginalis infection-associated risk of cervical cancer: A meta-analysis. Eur J Obstet Gynecol Reprod Biol 2018; 228:166.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Viikki M, Pukkala E, Nieminen P, Hakama M. Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol 2000; 39:71.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roeters AM, Boon ME, van Haaften M, et al. Inflammatory events as detected in cervical smears and squamous intraepithelial lesions. Diagn Cytopathol 2010; 38:85.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Depuydt CE, Leuridan E, Van Damme P, et al. Epidemiology of Trichomonas vaginalis and human papillomavirus infection detected by real-time PCR in flanders. Gynecol Obstet Invest 2010; 70:273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Belfort IKP, Cunha APA, Mendes FPB, et al. Trichomonas vaginalis as a risk factor for human papillomavirus: a study with women undergoing cervical cancer screening in a northeast region of Brazil. BMC Womens Health 2021; 21:174.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mann JR, McDermott S, Gill T. Sexually transmitted infection is associated with increased risk of preterm birth in South Carolina women insured by Medicaid. J Matern Fetal Neonatal Med 2010; 23:563.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mann JR, McDermott S, Barnes TL, et al. Trichomoniasis in pregnancy and mental retardation in children. Ann Epidemiol 2009; 19:891.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mann JR, McDermott S. Are maternal genitourinary infection and pre-eclampsia associated with ADHD in school-aged children? J Atten Disord 2011; 15:667.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mann JR, McDermott S, Gregg A, Gill TJ. Maternal genitourinary infection and small for gestational age. Am J Perinatol 2009; 26:667.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silver BJ, Guy RJ, Kaldor JM, et al. Trichomonas vaginalis as a cause of perinatal morbidity: A systematic review and meta-analysis. Sex Transm Dis 2014; 41:369.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Gerwen OT, Craig-Kuhn MC, Jones AT, et al. Trichomoniasis and adverse birth outcomes: a systematic review and meta-analysis. BJOG 2021; 128:1907.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hobbs MM, Kazembe P, Reed AW, et al. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex Transm Dis 1999; 26:381.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuberski T. Trichomonas vaginalis associated with nongonococcal urethritis and prostatitis. Sex Transm Dis 1980; 7:135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cudmore SL, Delgaty KL, Hayward-McClelland SF, et al. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis. Clin Microbiol Rev 2004; 17:783.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           LANCELEY F, MCENTEGART MG. Trichomonas vaginalis in the male; the experimental infection of a few volunteers. Lancet 1953; 1:668.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Skerk V, Krhen I, Schonwald S, et al. The role of unusual pathogens in prostatitis syndrome. Int J Antimicrob Agents 2004; 24 Suppl 1:S53.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim JH, Han IH, Kim SS, et al. Interaction between Trichomonas vaginalis and the Prostate Epithelium. Korean J Parasitol 2017; 55:213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shiadeh MN, Niyyati M, Fallahi S, Rostami A. Human parasitic protozoan infection to infertility: a systematic review. Parasitol Res 2016; 115:469.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gopalkrishnan K, Hinduja IN, Kumar TC. Semen characteristics of asymptomatic males affected by Trichomonas vaginalis. J In Vitro Fert Embryo Transf 1990; 7:165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Najafi A, Chaechi Nosrati MR, Ghasemi E, et al. Is there association between Trichomonas vaginalis infection and prostate cancer risk?: A systematic review and meta-analysis. Microb Pathog 2019; 137:103752.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Han IH, Song HO, Ryu JS. IL-6 produced by prostate epithelial cells stimulated with Trichomonas vaginalis promotes proliferation of prostate cancer cells by inducing M2 polarization of THP-1-derived macrophages. PLoS Negl Trop Dis 2020; 14:e0008126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith LM, Wang M, Zangwill K, Yeh S. Trichomonas vaginalis infection in a premature newborn. J Perinatol 2002; 22:502.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Temesvári P, Kerekes A, Tege A, Szarka K. Demonstration of Trichomonas vaginalis in tracheal aspirates in infants with early respiratory failure. J Matern Fetal Neonatal Med 2002; 11:347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoffman DJ, Brown GD, Wirth FH, et al. Urinary tract infection with Trichomonas vaginalis in a premature newborn infant and the development of chronic lung disease. J Perinatol 2003; 23:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carter JE, Whithaus KC. Neonatal respiratory tract involvement by Trichomonas vaginalis: A case report and review of the literature. Am J Trop Med Hyg 2008; 78:17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vaginitis in Nonpregnant Patients: ACOG Practice Bulletin, Number 215. Obstet Gynecol 2020; 135:e1. Reaffirmed 2022.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nye MB, Schwebke JR, Body BA. Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am J Obstet Gynecol 2009; 200:188.e1.
          </a>
         </li>
         <li class="breakAll">
          Guidelines for the management of symptomatic sexually transmitted infections. World Health Organization. July, 2021. https://www.who.int/publications/i/item/9789240024168. (Accessed on June 30, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tuddenham S, Hamill MM, Ghanem KG. Diagnosis and Treatment of Sexually Transmitted Infections: A Review. JAMA 2022; 327:161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kissinger P. Epidemiology and treatment of trichomoniasis. Curr Infect Dis Rep 2015; 17:484.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim TG, Young MR, Goggins ER, et al. Trichomonas vaginalis in Pregnancy: Patterns and Predictors of Testing, Infection, and Treatment. Obstet Gynecol 2020; 135:1136.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krieger JN, Tam MR, Stevens CE, et al. Diagnosis of trichomoniasis. Comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens. JAMA 1988; 259:1223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stoner KA, Rabe LK, Meyn LA, Hillier SL. Survival of Trichomonas vaginalis in wet preparation and on wet mount. Sex Transm Infect 2013; 89:485.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kingston MA, Bansal D, Carlin EM. 'Shelf life' of Trichomonas vaginalis. Int J STD AIDS 2003; 14:28.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Perl G. Errors in the diagnosis of trichomonas vaginalis infections as observed among 1199 patients. Obstet Gynecol 1972; 39:7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dan M, Sobel JD. Failure of nitazoxanide to cure trichomoniasis in three women. Sex Transm Dis 2007; 34:813.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hobbs MM, Seña AC. Modern diagnosis of Trichomonas vaginalis infection. Sex Transm Infect 2013; 89:434.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patil MJ, Nagamoti JM, Metgud SC. Diagnosis of Trichomonas Vaginalis from Vaginal Specimens by Wet Mount Microscopy, In Pouch TV Culture System, and PCR. J Glob Infect Dis 2012; 4:22.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Price CM, Peters RPH, Steyn J, et al. Prevalence and Detection of Trichomonas vaginalis in HIV-Infected Pregnant Women. Sex Transm Dis 2018; 45:332.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bruni MP, Freitas da Silveira M, Stauffert D, et al. Aptima Trichomonas vaginalis assay elucidates significant underdiagnosis of trichomoniasis among women in Brazil according to an observational study. Sex Transm Infect 2019; 95:129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levi MH, Torres J, Piña C, Klein RS. Comparison of the InPouch TV culture system and Diamond's modified medium for detection of Trichomonas vaginalis. J Clin Microbiol 1997; 35:3308.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Borchardt KA, Zhang MZ, Shing H, Flink K. A comparison of the sensitivity of the InPouch TV, Diamond's and Trichosel media for detection of Trichomonas vaginalis. Genitourin Med 1997; 73:297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lara-Torre E, Pinkerton JS. Accuracy of detection of trichomonas vaginalis organisms on a liquid-based papanicolaou smear. Am J Obstet Gynecol 2003; 188:354.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aslan DL, Gulbahce HE, Stelow EB, et al. The diagnosis of Trichomonas vaginalis in liquid-based Pap tests: correlation with PCR. Diagn Cytopathol 2005; 32:341.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wiese W, Patel SR, Patel SC, et al. A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis. Am J Med 2000; 108:301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sobel JD. Vulvovaginitis in healthy women. Compr Ther 1999; 25:335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chirenje ZM, Dhibi N, Handsfield HH, et al. The Etiology of Vaginal Discharge Syndrome in Zimbabwe: Results from the Zimbabwe STI Etiology Study. Sex Transm Dis 2018; 45:422.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barry MS, Ba Diallo A, Diadhiou M, et al. Accuracy of syndromic management in targeting vaginal and cervical infections among symptomatic women of reproductive age attending primary care clinics in Dakar, Senegal. Trop Med Int Health 2018; 23:541.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5453 Version 75.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35416973" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33045163" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Comprehensive Molecular Screening in a Cohort of Young Men Who Have Sex With Men and Transgender Women: Effect of Additive Rectal Specimen Source Collection and Analyte Testing.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18607317" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Prevalence of rectal Trichomonas vaginalis and Mycoplasma genitalium in male patients at the San Francisco STD clinic, 2005-2006.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28228954" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Can trichomoniasis cause pharyngitis? A case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15026404" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Evaluation of vaginal complaints.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24951156" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : What is the importance of zoonotic trichomonads for human health?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9564565" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Clinical and microbiological aspects of Trichomonas vaginalis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9564565" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Clinical and microbiological aspects of Trichomonas vaginalis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13661529" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Epidemiological studies on human trichomoniasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21305023" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Non-sexual transmission of Trichomonas vaginalis in adolescent girls attending school in Ndola, Zambia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22183836" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Ongoing sexually transmitted disease acquisition and risk-taking behavior among US HIV-infected patients in primary care: implications for prevention interventions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22902674" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Prevalence of urethral Trichomonas vaginalis in black and white men who have sex with men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34292926" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Sexually Transmitted Infections Treatment Guidelines, 2021.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Experimental human vaginal trichomoniasis
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23354954" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Mixed vaginitis-more than coinfection and with therapeutic implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28594779" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Clinical Validation of a Test for the Diagnosis of Vaginitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28594779" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Clinical Validation of a Test for the Diagnosis of Vaginitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32366602" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Characterising HIV and STIs among transgender female sex workers: a longitudinal analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29643195" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Diagnostic Performance of a Molecular Test versus Clinician Assessment of Vaginitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33347046" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Nucleic Acid Amplification Testing Compared With Cultures, Gram Stain, and Microscopy in the Diagnosis of Vaginitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34736269" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Performance of a Vaginal Panel Assay Compared With the Clinical Diagnosis of Vaginitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24928292" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29485986" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22622447" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Prevalence of Trichomonas vaginalis and coinfection with Chlamydia Trachomatis and neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29465684" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Screening for Trichomonas vaginalis in a Large High-Risk Population: Prevalence Among Men and Women Determined by Nucleic Acid Amplification Testing.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29247635" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Trichomonas vaginalis is most frequently detected in women at the age of peri-/premenopause: an unusual pattern for a sexually transmitted pathogen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34535306" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Trichomonas Infection Rates in Males Presenting to the Emergency Department for Sexually Transmitted Infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23354525" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Trichomonas vaginalis infection in men who submit self-collected penile swabs after internet recruitment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17143809" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Trichomonas vaginalis infection in male sexual partners: Implications for diagnosis, treatment, and prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7705860" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Barrier methods of contraception, spermicides, and sexually transmitted diseases: A review
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17043338" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17043338" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15118630" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Predictive value of the clinical diagnosis of lower genital tract infection in women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8435938" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Trichomonas vaginalis: A reemerging pathogen
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9243743" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16455885" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Use of an adaptation of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16288365" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15489349" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Trichomoniasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6965976" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Trichomonas vaginalis: Reevaluation of its clinical presentation and laboratory diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2403128" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11797180" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31719170" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Trichomonas vaginalis, endometritis and sequelae among women with clinically suspected pelvic inflammatory disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8465809" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Relation of tubal infertility to history of sexually transmitted diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8442924" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9449891" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Trichomonas vaginalis and amplification of HIV-1 transmission.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17262712" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11237825" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19008776" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9314871" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23605851" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Trichomoniasis and HIV interactions: A review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15319854" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24417784" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : An association between Trichomonas vaginalis and high-risk human papillomavirus in rural Tanzanian women undergoing cervical cancer screening.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8002180" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8566984" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Serum antibodies to Trichomonas vaginalis in invasive cervical cancer patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29980111" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Trichomonas vaginalis infection-associated risk of cervical cancer: A meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10752657" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Gynaecological infections as risk determinants of subsequent cervical neoplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19795485" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Inflammatory events as detected in cervical smears and squamous intraepithelial lesions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21051847" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Epidemiology of Trichomonas vaginalis and human papillomavirus infection detected by real-time PCR in flanders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33892709" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Trichomonas vaginalis as a risk factor for human papillomavirus: a study with women undergoing cervical cancer screening in a northeast region of Brazil.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19903113" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Sexually transmitted infection is associated with increased risk of preterm birth in South Carolina women insured by Medicaid.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19944351" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Trichomoniasis in pregnancy and mental retardation in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20837984" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Are maternal genitourinary infection and pre-eclampsia associated with ADHD in school-aged children?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19452428" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Maternal genitourinary infection and small for gestational age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24825333" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Trichomonas vaginalis as a cause of perinatal morbidity: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34036690" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Trichomoniasis and adverse birth outcomes: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10458630" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Trichomonas vaginalis as a cause of urethritis in Malawian men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6969451" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Trichomonas vaginalis associated with nongonococcal urethritis and prostatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15489348" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13036121" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Trichomonas vaginalis in the male; the experimental infection of a few volunteers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15364308" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : The role of unusual pathogens in prostatitis syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28506046" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Interaction between Trichomonas vaginalis and the Prostate Epithelium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26573517" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Human parasitic protozoan infection to infertility: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2380623" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Semen characteristics of asymptomatic males affected by Trichomonas vaginalis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31539586" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Is there association between Trichomonas vaginalis infection and prostate cancer risk?: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32196489" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : IL-6 produced by prostate epithelial cells stimulated with Trichomonas vaginalis promotes proliferation of prostate cancer cells by inducing M2 polarization of THP-1-derived macrophages.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12168131" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Trichomonas vaginalis infection in a premature newborn.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12389679" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Demonstration of Trichomonas vaginalis in tracheal aspirates in infants with early respiratory failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12556929" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Urinary tract infection with Trichomonas vaginalis in a premature newborn infant and the development of chronic lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18187779" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Neonatal respiratory tract involvement by Trichomonas vaginalis: A case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31856123" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Vaginitis in Nonpregnant Patients: ACOG Practice Bulletin, Number 215.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19185101" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19185101" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35015033" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Diagnosis and Treatment of Sexually Transmitted Infections: A Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25925796" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Epidemiology and treatment of trichomoniasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32282605" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Trichomonas vaginalis in Pregnancy: Patterns and Predictors of Testing, Infection, and Treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2448502" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Diagnosis of trichomoniasis. Comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23605849" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Survival of Trichomonas vaginalis in wet preparation and on wet mount.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12590789" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : 'Shelf life' of Trichomonas vaginalis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4536652" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Errors in the diagnosis of trichomonas vaginalis infections as observed among 1199 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17551415" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Failure of nitazoxanide to cure trichomoniasis in three women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23633669" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Modern diagnosis of Trichomonas vaginalis infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22529623" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Diagnosis of Trichomonas Vaginalis from Vaginal Specimens by Wet Mount Microscopy, In Pouch TV Culture System, and PCR.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29465686" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Prevalence and Detection of Trichomonas vaginalis in HIV-Infected Pregnant Women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30154157" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Aptima Trichomonas vaginalis assay elucidates significant underdiagnosis of trichomoniasis among women in Brazil according to an observational study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9399542" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Comparison of the InPouch TV culture system and Diamond's modified medium for detection of Trichomonas vaginalis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9389954" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : A comparison of the sensitivity of the InPouch TV, Diamond's and Trichosel media for detection of Trichomonas vaginalis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12592239" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Accuracy of detection of trichomonas vaginalis organisms on a liquid-based papanicolaou smear.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15880709" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : The diagnosis of Trichomonas vaginalis in liquid-based Pap tests: correlation with PCR.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11014723" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10470518" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Vulvovaginitis in healthy women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29465674" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : The Etiology of Vaginal Discharge Syndrome in Zimbabwe: Results from the Zimbabwe STI Etiology Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29505113" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Accuracy of syndromic management in targeting vaginal and cervical infections among symptomatic women of reproductive age attending primary care clinics in Dakar, Senegal.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
